Cryptococcosis: We should do better! [1]

Clinical Infectious Diseases

Volumn 43, Issue 7, 2006, Pages 948-949

  Antinori, Spinello ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; ANTIFUNGAL AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIFUNGAL ACTIVITY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG USE; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; LETTER; PRIORITY JOURNAL; AIDS RELATED COMPLEX; NOTE;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CRYPTOCOCCOSIS; CRYPTOCOCCUS; HUMANS; ITRACONAZOLE;

EID: 33748673341     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/507541     Document Type: Letter

References (11)

1. Ecevit IZ, Clancy CJ, Schmalfuss IM, Nguyen MH. The poor prognosis of central nervous system cryptococcosis among nonimmunosuppressed patients: a call for better disease recognition and evaluation of adjuncts to antifungal therapy. Clin Infect Dis 2006; 42: 1443-7.
2. Rozenbaum R, Rios Goncalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994; 18:369-80.
3. Mitchell DH, Sorrell TC, Allworth AM, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20:611-6.
4. Shih CC, Chen YC, Chang SC, Luh KT, Hsieh WC. Cryptococcal meningitis in non-HIV-infected patients. QJM 2000; 93:245-51.
5. Kontoyiannis DP, Peitsch WK, Reddy BT, et al. Cryptococcosi in patients with cancer. Clin Infect Dis 2001; 32:e145-50.
6. Wu G, Vilchez RA, Eidelman B, Fung J, Kormos R, Kusne S. Cryptococcal meningitis: an analysis among 5521 consecutive organ transplant recipients. Transpl Infect Dis 2002; 4: 183-8.
7. Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Cryptococcosis in human immunodeficiency virus-negative patients. Int J Infect Dis 2006; 10:72-8.
8. FIMUA Cryptococcosis Network. European Confederation of Medical Micology (ECMM) prospective survey of cryptococcosis: report from Italy. Med Mycol 2002; 40:507-17.
9. Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 2004; 363:1764-7.
10. Van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997; 337:15-21.
11. Leenders ACAP, Reiss P, Portegies P, et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. AIDS 1997; 11:1463-71.